TSI And TBII Panel
This blood test panel measures thyroid receptor antibodies (TSI and TBII) to help clarify Graves patterns, guide treatment decisions, and track trends over time.
This panel bundles multiple biomarker tests in one order—your report explains how results fit together.
This is a lab panel, meaning you get multiple thyroid receptor antibody measurements in one order. It is most often used when you and your clinician are trying to confirm (or rule out) Graves disease as the driver of hyperthyroid symptoms, or when you need a clearer picture than TSH and thyroid hormones alone can provide.
Because antibody results can be confusing and can change over time, the value of this panel is in how the results fit together and how they match your symptoms, thyroid hormone levels, and treatment plan.
Do I need this panel?
You may benefit from the TSI And TBII Panel if you have symptoms that suggest hyperthyroidism—such as palpitations, tremor, heat intolerance, anxiety, unintentional weight loss, frequent bowel movements, or new sleep disruption—and you want to understand whether an autoimmune process like Graves disease is likely.
This panel is also commonly considered when your basic thyroid labs (like TSH with free T4 and/or free T3) are abnormal but the “why” is still unclear. For example, a low TSH with high thyroid hormones can happen from Graves disease, thyroiditis, medication effects, or excess thyroid hormone intake; receptor antibody testing helps separate these possibilities.
If you are pregnant, planning pregnancy, or recently postpartum, receptor antibodies may matter because they can cross the placenta and, in some situations, affect fetal or newborn thyroid function. Your clinician may use these results to guide monitoring intensity.
This panel supports clinician-directed care and shared decision-making. It is not meant to diagnose you on its own, and it should be interpreted alongside your symptoms, exam findings (including eye symptoms), and companion thyroid labs.
Methods and reference ranges vary by lab; interpret TSI and TBII results using the ranges shown on your report and in the context of your thyroid hormone tests and medications.
Lab testing
Order the TSI And TBII Panel
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this panel with Vitals Vault
Vitals Vault makes it straightforward to order a thyroid receptor antibody lab panel when you want more clarity than a quick thyroid screen can offer. You can use this panel to help confirm an autoimmune pattern consistent with Graves disease, to establish a baseline before treatment, or to track antibody trends over time.
After you receive results, PocketMD can help you translate a multi-marker panel into plain language: what each marker represents, which patterns tend to align with Graves versus other causes of hyperthyroidism, and what follow-up questions to bring to your clinician.
If your goal is a more complete thyroid map, you can pair this antibody panel with a broader thyroid hormone package (TSH, free T4, total T4, free T3, total T3) so you are not trying to interpret antibodies without the hormone context they act through.
- Order online and test through established lab networks
- Designed for trend tracking (baseline and follow-up testing)
- PocketMD support for interpreting multi-marker patterns
Key benefits of the TSI And TBII Panel
- Helps clarify whether hyperthyroid labs and symptoms are consistent with Graves disease (autoimmune thyroid stimulation).
- Separates “why” your thyroid is overactive when TSH and thyroid hormones alone are not specific.
- Provides two complementary views of thyroid receptor antibodies, reducing overreliance on a single marker.
- Supports treatment planning and monitoring (for example, trending antibodies during antithyroid drug therapy).
- Adds clinically useful context in pregnancy planning or pregnancy when receptor antibodies may influence monitoring decisions.
- Helps interpret confusing scenarios such as fluctuating thyroid levels, recent thyroiditis, or mixed lab patterns.
- Creates a baseline you can compare against future panels to understand direction of change, not just a single snapshot.
What is the TSI And TBII panel?
The TSI And TBII Panel is a blood test panel that measures thyroid-stimulating immunoglobulin (TSI) and thyroid-binding inhibitory immunoglobulin (TBII). Both tests relate to antibodies that target the thyroid-stimulating hormone (TSH) receptor on thyroid cells.
In Graves disease, your immune system can produce antibodies that bind to the TSH receptor and stimulate it, pushing the thyroid to make and release more thyroid hormone. That stimulation can lead to low TSH and high free T4 and/or free T3, along with symptoms of hyperthyroidism.
TSI is designed to detect antibodies with stimulating activity (the type most associated with Graves hyperthyroidism). TBII is a broader “receptor antibody” measurement that reflects antibodies that bind the receptor and interfere with normal binding; depending on the assay, TBII can capture stimulating, blocking, or neutral antibodies. Because they are not identical tests, ordering them together can help you and your clinician interpret borderline or conflicting situations.
This panel does not replace thyroid hormone testing. Antibodies help explain the cause, while TSH and thyroid hormones show the physiologic effect on your body right now. Many people get the most value when this panel is interpreted alongside a full thyroid hormone set and, when relevant, other thyroid antibodies (such as TPO and thyroglobulin antibodies).
How these markers fit into Graves workups
When Graves is the suspected cause of hyperthyroidism, receptor antibody testing can support the diagnosis and may reduce the need for other confirmatory steps in some cases. It can also be helpful when imaging is not desired or is less practical (for example, during pregnancy).
Why two receptor antibody tests can be useful
Different assays emphasize different antibody behaviors (stimulating activity versus receptor binding). If one result is borderline, the second marker can add context. If both are clearly positive, the pattern is more convincing. If both are negative, it pushes the differential toward non-Graves causes—though timing, treatment, and lab methods still matter.
What do my panel results mean?
Low or negative receptor antibodies across the panel
When both TSI and TBII are negative (or clearly below the lab’s cutoff), it makes an active Graves antibody pattern less likely at the time of testing. If you still have hyperthyroid labs or symptoms, your clinician may look more closely at other causes such as thyroiditis (temporary hormone “leak”), medication or supplement effects (including thyroid hormone), iodine exposure, or less common pituitary patterns. A negative panel does not automatically rule out Graves in every situation—antibody levels can fall with treatment, vary by assay, or be lower early or late in the disease—so the next step is usually to interpret the panel alongside TSH, free T4, free T3, and your clinical timeline.
Results that fit the clinical question and are consistent with your overall thyroid picture
There is not a single “optimal” antibody number for everyone, because the goal depends on why you tested. If you are evaluating possible Graves disease, a clear positive pattern (especially when paired with low TSH and high thyroid hormones) can be the most informative outcome because it explains the driver of hyperthyroidism. If you are monitoring known Graves on treatment, a stable or falling antibody pattern may be reassuring when it matches improving symptoms and normalizing thyroid hormones. The most useful interpretation is pattern-based: antibodies (cause) plus hormones (effect) plus symptoms (impact).
High or positive receptor antibodies (TSI and/or TBII)
A positive TSI and/or TBII suggests that TSH-receptor–targeting antibodies are present. When this aligns with low TSH and elevated free T4 and/or free T3, it supports an autoimmune pattern consistent with Graves disease. If one marker is positive and the other is negative, it can still be clinically meaningful—assays differ, and antibody behavior can be mixed—so your clinician may weigh the result against your hormone levels, exam findings, and whether you are already on antithyroid medication. Higher antibody activity can sometimes correlate with more active autoimmune stimulation, but the number alone should not be used to predict severity without the rest of your thyroid panel and your clinical course.
Factors that influence TSI/TBII results
Treatment and timing can shift antibody levels. Antithyroid drugs, changes in thyroid status, and the natural waxing and waning of autoimmune activity can all affect results, so trends over time are often more informative than a single draw. Pregnancy and the postpartum period can change immune activity and may alter antibody levels and clinical relevance. Lab-to-lab differences matter: TSI and TBII are method-dependent, and “positive” thresholds are not identical across assays. Finally, interpretation depends on companion labs—TSH, free T4, and free T3—because antibodies explain the cause, but hormones show what your tissues are experiencing right now.
What’s included in this panel
- Trab
- Tsi (Thyroid Stimulating Immunoglobulin)
Frequently Asked Questions
Do I need to fast for the TSI And TBII Panel?
Fasting is usually not required for thyroid receptor antibody testing. If you are combining this panel with other labs (like lipids or glucose), follow the fasting instructions for those tests.
How is this panel different from a standard thyroid panel (TSH, free T4, free T3)?
TSH and thyroid hormones show how active your thyroid is right now. This panel focuses on the likely cause by measuring antibodies that target the TSH receptor, which is especially useful when Graves disease is suspected or when the reason for abnormal thyroid hormones is unclear.
If my TSI is positive, does that mean I definitely have Graves disease?
A positive TSI strongly supports a Graves pattern, especially when it matches low TSH and elevated thyroid hormones. Diagnosis is still clinical, meaning your clinician considers symptoms, exam findings (including eye symptoms), imaging when appropriate, and your full lab picture.
Can TBII be positive when TSI is negative (or the other way around)?
Yes. These tests are related but not identical. TBII reflects receptor-binding antibodies more broadly, while TSI focuses on stimulating activity. Differences in assay design, timing, and treatment can lead to one being positive while the other is negative, which is why the panel view can be helpful.
Can treatment change my antibody results?
Yes. Antibody levels can decrease over time with treatment and with changes in autoimmune activity. If you are monitoring known Graves disease, your clinician may use trends in antibodies along with TSH and thyroid hormones to understand disease activity and relapse risk.
Is this panel useful during pregnancy or when trying to conceive?
It can be. TSH receptor antibodies can cross the placenta, and in certain situations they influence how closely pregnancy is monitored. Decisions about testing and follow-up should be individualized with your obstetric and endocrine care team.
Should I order this panel by itself or with other thyroid tests?
If you are actively symptomatic or have abnormal thyroid labs, this panel is usually most informative when paired with TSH and thyroid hormones (free T4 and free T3, and sometimes total T4/T3). Antibodies explain the driver, but hormones show the current physiologic effect.